Home  >  News
you can get e-magazine links on WhatsApp.Click here
  US FDA grants breakthrough therapy status to Dizal Pharma’s DZD9008 to treat patients with locally advanced or metastatic NSCLC with EGFR exon20 insertion,   January 28, 2022
  Merck’s Keytruda gets European approval as adjuvant therapy for certain patients with RCC following surgery,   January 28, 2022
  US FDA grants priority review to Roche’s sNDA for use of Evrysdi to treat pre-symptomatic babies under 2 months of age with SMA,   January 27, 2022
  Innovent gets Hong Kong Department of Health approval for Pemazyre to treat adults with locally advanced or metastatic cholangiocarcinoma with FGFR2 fusion,   January 25, 2022
  Ipsen receives Health Canada approval for Sohonos to treat fibrodysplasia ossificans progressive,   January 25, 2022
  US FDA issues Complete Response Letter to Merck’s NDA for gefapixant,   January 25, 2022
  US FDA approves Applied Pharma’s IND application for next generation selective RET inhibitor, APS03118 to treat unlimited cancers,   January 24, 2022
  Gilead Sciences’ Veklury gets US FDA approval to treat non-hospitalized patients at high risk for Covid-19 disease progression,   January 24, 2022
  AbbVie’s Skyrizi receives US FDA approval to treat adults with active psoriatic arthritis,   January 24, 2022
  Regulus completes Pre-IND meeting with US FDA for RGLS8429,   January 22, 2022
  Pfizer, Opko’s Ngenla to treat paediatric growth hormone deficiency receives Japanese approval,   January 22, 2022
  Chugai Pharma’s Actemra gets Japanese approval for additional indication of SARS-CoV-2 pneumonia,   January 22, 2022
  US FDA completes review of Lannett’s IND application for biosimilar insulin glargine,   January 22, 2022
  Japan’s MHLW approves argenx’s Vyvgart to treat generalized myasthenia gravis,   January 21, 2022
  WHO announces update of guidelines on diagnosis, prevention and management of cryptococcal disease in HIV-infected adults,   January 21, 2022
  Boehringer Ingelheim receives Global Top Employer award from Top Employers Institute,   January 21, 2022
  Amgen’s Lumakras receives Japanese approval to treat patients with KRAS G12C-mutated advanced NSCLC,   January 21, 2022
  China NMPA accepts CANbridge Pharma’s NDA for maralixibat to treat CAN108 Alagille syndrome,   January 20, 2022
  Smith+Nephew acquires US cementless partial knee system, Engage Surgical,   January 20, 2022
  Daiichi Sankyo to divest certain cardiovascular and other legacy products to Cosette Pharma in US,   January 20, 2022

Copyright © 2016 Saffron Media Pvt. Ltd |